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Abstract
The recent introduction of bronchoscopically recovered cryobiopsy of lung tissue has opened up new possibilities
in the diagnosis of neoplastic and non-neoplastic lung diseases in various aspects. Most notably the morphological
diagnosis of peripheral lung biopsies promises to achieve a better yield with a high quality of specimens. To better
understand this phenomenon, its diagnostic options and perspectives, this study morphometrically compares 15
cryobiopsies and 18 transbronchial forceps biopsies of peripheral lung tissue a priori without considering clinical hit
ratio or integration of results in the clinical diagnostic processing. Cryotechnically harvested specimens were
significantly larger (mean: 17.1 ± 10.7 mm
2 versus 3.8 ± 4.0 mm
2) and contained alveolar tissue more often. If
present, the alveolar part in cryobiopsies exceeded the one of forceps biopsies. The alveolar tissue of crybiopsy
specimens did not show any artefacts. Based on these results cryotechnique seems to open up new perspectives
in bronchoscopic diagnosis of lung disease.
Background
The diagnostic yield of transbronchial lung biopsy (TBB)
by forceps is a function of biopsy quality defined by spe-
cimen size and preservation of tissue architecture. In
addition, artifacts may considerably affect the interpreta-
tion of the tissue obtained.
The tissue sample delivered in clinical routine usually
consists of one or more lung pieces averaging 1 to 2
mm in size [1-4]. It is difficult to report the diagnostic
accuracy of TBB, because they are taken for various
indications. The majority of large case series report a
diagnostic accuracy of 50% to 70% depending on the
indication, size and location of the lesion [1,3,5-10]. Per-
ipheral tumour lesions can be diagnosed in up to 57%
of patients [9,11]. In diffuse lung diseases, the overall
efficacy is probably lower, whereas the technique seems
to be highly efficient in sarcoidosis and cryptogenic
organising pneumonia. The results in usual interstitial
pneumonia, pneumoconiosis or pulmonary histiocytosis
X are poor [1,4,10,12]. This large variation is due to the
different importance of alveolar tissue which is usually
underrepresented in TBB. Moreover, information about
distribution of the pathologic pattern throughout the
lungs can principally not be provided by TBB.
Cryosurgical techniques have been used in the airways
as early as 1968 [13]. The cryotechnique was mainly
used for palliative treatment of obstructing endobron-
chial tumors [14-16]. Cryotechniques use very low tem-
peratures induced by rapid expansion of gas released at
high flow (Joule-Thompson effect) and leads to adhesion
of the specimen to the probe. Such pieces of tissue can
be extracted with the freeze-thaw cycle without increas-
ing the danger of life threatening complications [17,18].
With the implementation of flexible probes for the
diagnostic work-up of patients with endobronchial
tumor lesions, cryobiopsy was introduced recently on a
routine basis and found to be also safe in a routine diag-
nostic setting [17,19]. The biopsies obtained in these
experiments were reported to be larger and diagnosti-
cally more valuable. An animal study supports these
hypothesis by showing that the preservation of samples
and sample size can be improved by cryotechnique
[17,18]. Similar results have been shown from central
cryobiopsies in a study on efficacy of cryobiospies in
cancer patients [20].
The aim of our study was to evaluate cryotechnique
for peripheral transbronchial lung biopsies with the
focus on sample adequacy for diagnostic purposes with
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retrieved.
Methods
This is a prospective case series of 15 patients, who
underwent flexible bronchoscopy including transbron-
chial cryobiopsies. A series of 18 patients undergoing
conventional peripheral transbronchial biopsies by for-
ceps were selected as the control group. Patient charac-
teristics (localization, clinical indication) are listed in
tables 1 and 2.
Cryobiopsies and conventional transbronchial biopsies
were obtained during flexible bronchoscopy with seda-
tion and local anaesthesia using a flexible bronchoscope
(1T 160 and 1T 180, Olympus Corp. Tokyo Japan). The
cryoprobe or forceps were introduced into the selected
area under fluoroscopic guidance. For all samples, a dis-
tance of approximately 10-20 mm from the thoracic
wall was considered optimal. Once brought into posi-
tion, the probe was cooled for approximately five sec-
onds and then retracted with the frozen lung tissue
being attached on the probe’s tip. The frozen specimen
was thawed in saline and fixed in 4% buffered formalin.
All specimens won by TBB were stored in Formalin
only and the forceps size used was 1.8 mm (Boston
Scientific Radial Jaw™ Natick, MA USA).
For this study a signed informed consent of all patients
was obtained. The cryotechnique is a technology author-
ized by the German medicinal products act and was
applied depending on the individual medical indication.
Since there was no patient randomization and no speci-
mens beyond the medical indication were harvested, for-
mal approval of an ethics committee was not obtained.
Only one cryobiopsy was taken, whereas the number
of conventional TBB varied from 1 to 4, depending on
the investigator. All biopsies were processed convention-
ally by serial sectioning of at least 12 H&E stained sec-
tion steps to avoid incomplete sectioning of particles.
Subsequently the biopsies were rated regarding quality
and quantity by two experienced lung pathologists (SG
& TM), rendering a consensus about biopsy quality
as well as presence and amount of artefacts (Tables 1
and 2).
Hematoxylin-eosine slides were scanned by a ZEISS-
MIRAX Midi Slide scanning system using the Mirax
Viewer Image Software Ver[1,6]. (Zeiss Microimaging,
Oberkochen, Germany and 3DTech, Budapest, Hungary)
(Figure 1). The total area of the biopsy specimens and
the area of the alveolar part were measured by interac-
tive circling of the biopsy section and its alveolar part.
In each conventional TBB, all tissue samples were mea-
sured, but only the largest in size was included in the
subsequent analysis (see discussion). All areas were cal-
culated automatically and expressed in μm
2.
Statistics
All data were analyzed and processed using statistical
software (Statistical Package for Social Sciences, Version
14.0; SPSS, Chicago, IL, USA) on a Windows XP operat-
ing system (Microsoft; Redmond, WA, USA). Results
were expressed as frequencies or as mean ± SD unless
indicated otherwise. The c2-test was used to compare
proportions, and Student t test was used to compare
means. The significance level of all analyses was set to
5%, and exact p values are reported. Results were
expressed using descriptive statistics.
Table 1 Measurements of the cryobiopsies
Specimen’s
number
Whole area
[mm
2]
Alveolar part within
biopsy
Area of alveolar part
[mm
2]
Artifacts of alveolar
part
Localisation Clinical
indication
1 31.885 No OL right Fibrosis
2 0.633 No ML Infiltration
3 4.913 Yes 1.799 None ML Infiltration
4 8.813 Yes 5.379 None OL left Infiltration
5 28.699 Yes 22.689 None Lingula Fibrosis
6 9.125 No OL right Fibrosis
7 29.353 Yes 13.303 None OL left CUP
8 21.299 Yes 7.035 None OL right Fibrosis
9 16.259 No Ul right Infiltration
10 14.613 Yes 13.204 None OL right Infiltration
11 13.815 Yes 0.449 None ML Infiltration
12 31.7999 Yes 25.155 None UL left Infiltration
13 28.202 Yes 24.979 None ML ILD
14 6.304 Yes 5.684 None UL left ILD
15 10.440 Yes 7.503 None UL left Infiltration
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Morphometric data of all samples including presence of
alveolar part, its size and artefacts within alveolar tissue
are listed in tables 1 and 2, and representive specimens
retrieved with the two methods under comparison are
illustrated in Figure 2 and 3.
Cryoprobes were larger and much more representative
of real lung structure featuring pathological attributes as
compared to small biopsy specimens of the forceps
technique (Figure 1). Specimen size in cryobiopsies was
significantly larger than in those obtained by forceps
(mean: 17.1 ± 10.7 μm
2 versus 3.8 ± 4.0 μm
2,n=1 5
and 18 respectively; p < 0.001) (Figure 2). In cryobiop-
sies, alveolar tissue was found in 11 of 15 (73%), in for-
ceps biopsies only in 10 of 18 (56%), thus showing a
trend for cryobiopsy containing alveolar tissue more
Table 2 Measurements of the forceps biopsies
Specimen’s
number
Whole area of the largest
specimen [mm
2]
Alveolar part within
biopsy
Area of alveolar
part [mm
2]
Artifacts of
alleolar part
Localisation Clinical
indication
1 2.333 Yes 1.058 Severe UL right Fibrosis
2 2.093 Yes 0.982 Mild OL right Fibrosis
3 1.007 No ML Fibrosis
4 1.384 No ML Fibrosis
5 4.344 Yes 1.612 Mild Ul left ILD
6 1.714 Yes 1.105 Mild Lingula Infiltration
7 3.684 Yes 1.195 Moderate OL right Infiltration
8 5.142 Yes 2.674 Moderate OL right Infiltration
9 2.688 Yes 0.430 Severe OL right Infiltration
10 11.828 No OL right Peripheral
lesion
11 2.424 Yes 1.511 Moderate UL left Peripheral
lesion
12 0.572 No ML Infiltration
13 2.806 Yes 2.372 Severe UL right Fibrosis
14 1.422 No OL right Infiltration
15 6.817 Yes 5.972 moderate UL right Infiltration
16 2.043 No UL right Infiltration
17 15.713 No UL right Infiltration
18 0.366 No Lingula Fibrosis
Figure 1 left: Cryobiopsy, right: Conventional forceps biopsy.
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either contained only bronchial mucosa and cartilage or
proved to be flat long bands of inner bronchial wall lin-
ing, the latter phenomenon exclusively seen in cryop-
robes. In specimens with alveolar tissue, its size was
significantly larger in the cryobiopsies (11.6 ± 9.1 μm
2
versus 1.9 ± 1.6 μm
2 in the forceps group, n = 11 and
10 respectively; p = 0.004) (Figure 3). When the pathol-
ogists rated the presence of artefacts within the alveolar
tissues, none of the specimens taken by cryobiopsy tech-
nique (0/11; 0%) showed parenchymal damage due to
compression, whereas all (10/10; 100%; p = 0.005) for-
ceps samples demonstrated at least mild parenchymal
changes.
In both groups of patients there were no complication
in terms of pneumothorax. In one patient of the forceps
biopsy group a major bleeding (> 3 min) occurred with-
out need of further intervention.
Discussion
Transbronchial forceps biopsy is a well accepted and
established retrieval tool for the histologic analysis of
parenchymal lung disease [1]. The requirement of histo-
logically proven diagnosis in suspected lung cancer is
evident. However, on the background of tumor hetero-
geneity, forceps biopsies are always hampered by small
sample sizes and thus uncertain representation for the
tumor. In addition, larger samples will likely become
even more important regarding the steadily increasing
amount of information that is expected to be gathered
from tissue samples in pinhead size. Particularly surface
and receptor analyses, prognostic or predictive genetic
markers and/or upcoming epigenetic changes will
become more important.
In non-neoplastic diseases a number of entities like
sarcoidosis or bronchiolitis obliterans may be diagnosed
on material obtained by transbronchial forceps biopsy.
Thus far, the efficacy of TBB in non-neoplastic lung dis-
eases has only been addressed in a few studies
[1,4,10,12].
Small size is the major factor limiting the usefulness
of TBB in clinical practice. Therefore the adequacy of
samples has always been a matter of debate. In needle
biopsies of solid organs such as kidney or liver with
histologically distinct and thus countable structures (e.
g., number of glomeruli), specimen adequacy can be
determined easily. In contrast, specimen adequacy in
lung biopsy has not yet been clearly defined and
depends on clinical context. However no such
approach has been implemented, because alveoli vary
largely in size, shape and quality and cannot be easily
rated. Moreover, two separate histologic structures -
bronchioli and alveoli - should be present in a biopsy.
Additionally there are several artifacts, which are typi-
cal for a forceps biopsy such as atelectasis, intraalveo-
lar hemorrhage and so called bubble artifacts [4]. The
frequent presence of artificial atelectasis may obscure
diagnostic features and also be misinterpreted as inter-
stitial fibrosis [10]. Several studies have rated the ade-
quacy of the transbronchial biopsy based on alveolar
content and specimen size. In a multivariate analysis,
the number of alveolar spaces necessary for an ade-
quate biopsy was defined as 20 [6]. Morphometry has
been shown to be an efficient method to evaluate sam-
p l es i z e[ 6 ] .
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Figure 2 Specimen Size, graph in μm
2, statistical data in mm
2.
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samples in bronchial biopsy seems to be the introduc-
tion of modern cryoprobes. With this technique, the
sample is collected while still being frozen, with the tis-
sue attached on the frozen probe’s tip. The value of the
biopsy under diagnostic aspects is influenced not only
b yt h es i z ei t s e l fb u tb yt h ea b s o l u t ea sw e l la sr e l a t i v e
content of alveolar structures, bronchial wall and neo-
plastic or reactive changes of the tissue samples
[1,2,6,7,9,12,18].
In our series the size of the biopsy specimens differed
significantly between cryoprobes and TBB specimens.
However it has to be emphasized that in each TBB only
one of the up to 4 biopsies was included in the analysis.
Usually we decided to include the largest piece. In cases
lacking alveolar tissue, present in other biopsies of the
case, we included the largest alveoli-bearing biopsy spe-
cimen. The rationale behind this was the fact that for
t h ed i a g n o s t i cv a l u eo fab i o p s yo n l yc o n t i n u o u st i s s u e
areas can be included in the diagnostic process, as topo-
graphic information is essential in histopathology, espe-
cially in diagnoses predominantly driven by pattern
information. Strictly speaking every specimen in TBB
has to be interpreted for its own, as the exact topo-
graphic relation between specimens of different biopsy
site remains unclear, at least for the histopathologist.
Our results show an important difference between for-
ceps biopsy and cryobiopsy. The latter samples are lar-
ger, and a trend to superiority with respect to the
alveolar tissue fraction is observable. In the group of
cryobiopsies we found alveolar tissue in a higher pro-
portion of cases as compared to the group of forceps
biopsies (73 vs 56%). The absolute value as well as the
relative amount of alveoli is undoubtedly superior in the
cryoprobe. In addition, artifacts in the alveolar part were
not observed in the cryogroup but in each sample
obtained by forceps biopsy.
The increased amount of tissue available for histologi-
cal and molecular access may significantly improve the
diagnostic value of bronchoscopical lung biopsies which
has to be investigated in further studies.
Conclusions
Major findings of this study were: 1. Cryobiopsy speci-
mens are significantly larger than those obtained by for-
ceps transbronchial biopsies. 2. There was a tendency
for alveolar tissue to be recovered more likely using
cryobiopsies. 3. The size of the alveolar part in cryo-
biopsy specimens was significantly larger compared to
specimens obtained by forceps. 4. Cryobiopsies appear
of higher quality to the pathologist lacking more or less
any artifacts in the alveolar parts of specimens. Cryo-
technique is an important new tool for the broncho-
scopic diagnosis of lung disease. The method is superior
to TBB with a forceps in terms of sample size and qual-
ity. Whether this technique can replace even open surgi-
cal biopsy for the diagnosis of parenchymal lung disease
needs to be addressed by prospective studies.
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